SHANK2 and Alzheimer disease: To assess whether patients with Alzheimer's Disease (AD) exhibit similar reductions in Zn2+ and ProSAP/Shank levels in the hippocampus, we analyzed brain sections from 14 control and AD patients (Table 1).